262 related articles for article (PubMed ID: 23906771)
1. Modulation of cerebral malaria by curcumin as an adjunctive therapy.
Jain K; Sood S; Gowthamarajan K
Braz J Infect Dis; 2013; 17(5):579-91. PubMed ID: 23906771
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive therapy for severe malaria: a review and critical appraisal.
Varo R; Crowley VM; Sitoe A; Madrid L; Serghides L; Kain KC; Bassat Q
Malar J; 2018 Jan; 17(1):47. PubMed ID: 29361945
[TBL] [Abstract][Full Text] [Related]
3. The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria.
Mimche PN; Taramelli D; Vivas L
Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S10. PubMed ID: 21411011
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.
John CC; Kutamba E; Mugarura K; Opoka RO
Expert Rev Anti Infect Ther; 2010 Sep; 8(9):997-1008. PubMed ID: 20818944
[TBL] [Abstract][Full Text] [Related]
5. Nanotized curcumin-benzothiophene conjugate: A potential combination for treatment of cerebral malaria.
Ghosh A; Banerjee T
IUBMB Life; 2020 Dec; 72(12):2637-2650. PubMed ID: 33037778
[TBL] [Abstract][Full Text] [Related]
6. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment.
Newton CR; Krishna S
Pharmacol Ther; 1998 Jul; 79(1):1-53. PubMed ID: 9719344
[TBL] [Abstract][Full Text] [Related]
7. Severe malaria: what's new on the pathogenesis front?
Wassmer SC; Grau GE
Int J Parasitol; 2017 Feb; 47(2-3):145-152. PubMed ID: 27670365
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
Higgins SJ; Kain KC; Liles WC
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):803-19. PubMed ID: 21905788
[TBL] [Abstract][Full Text] [Related]
9. Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria.
Dai M; Reznik SE; Spray DC; Weiss LM; Tanowitz HB; Gulinello M; Desruisseaux MS
Microbes Infect; 2010 Dec; 12(14-15):1198-207. PubMed ID: 20800692
[TBL] [Abstract][Full Text] [Related]
10. [Neurologic complications of malaria infection].
Hamann G; Schimrigk K
Fortschr Neurol Psychiatr; 1993 Feb; 61(2):46-54. PubMed ID: 8449477
[TBL] [Abstract][Full Text] [Related]
11. Curcumin for malaria therapy.
Reddy RC; Vatsala PG; Keshamouni VG; Padmanaban G; Rangarajan PN
Biochem Biophys Res Commun; 2005 Jan; 326(2):472-4. PubMed ID: 15582601
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model.
Dormoi J; Briolant S; Pascual A; Desgrouas C; Travaillé C; Pradines B
Malar J; 2013 Aug; 12():302. PubMed ID: 23988087
[TBL] [Abstract][Full Text] [Related]
13. Synthetic oleanane triterpenoids enhance blood brain barrier integrity and improve survival in experimental cerebral malaria.
Crowley VM; Ayi K; Lu Z; Liby KT; Sporn M; Kain KC
Malar J; 2017 Nov; 16(1):463. PubMed ID: 29137631
[TBL] [Abstract][Full Text] [Related]
14. Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies.
Zimmerman GA; Castro-Faria-Neto H
Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1209-12. PubMed ID: 21073283
[No Abstract] [Full Text] [Related]
15. Rocaglates as dual-targeting agents for experimental cerebral malaria.
Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.
Campos AC; Brant F; Miranda AS; Machado FS; Teixeira AL
Neuroscience; 2015 Mar; 289():166-80. PubMed ID: 25595981
[TBL] [Abstract][Full Text] [Related]
17. Neurological manifestations of falciparum malaria.
Newton CR; Warrell DA
Ann Neurol; 1998 Jun; 43(6):695-702. PubMed ID: 9629838
[TBL] [Abstract][Full Text] [Related]
18. Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria.
Dende C; Meena J; Nagarajan P; Nagaraj VA; Panda AK; Padmanaban G
Sci Rep; 2017 Aug; 7(1):10062. PubMed ID: 28855623
[TBL] [Abstract][Full Text] [Related]
19. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
[TBL] [Abstract][Full Text] [Related]
20. A single rapamycin dose protects against late-stage experimental cerebral malaria via modulation of host immunity, endothelial activation and parasite sequestration.
Mejia P; Treviño-Villarreal JH; Reynolds JS; De Niz M; Thompson A; Marti M; Mitchell JR
Malar J; 2017 Nov; 16(1):455. PubMed ID: 29121917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
